Search Tag: Radiomics
2024 07 May
The incidence of thyroid nodules has risen significantly in recent decades, with detection rates as high as 65% in the general population. Despite this, only a small percentage of nodules are cancerous. It's crucial to accurately distinguish between benign and malignant nodules for proper clinical management. While fine-needle aspiration biopsy...Read more
2024 12 Apr
Intrahepatic cholangiocarcinoma (ICC) is the second most common liver cancer after hepatocellular carcinoma, with rising global incidence and mortality rates. Surgical resection is a curative approach for ICC. However, due to non-specific symptoms, 70% of patients are diagnosed at advanced stages with unresectable tumours, leading to a poor prognosis...Read more
2024 19 Mar
Renal cell carcinoma (RCC) is the most common kidney malignancy, with clear cell renal cell carcinoma (ccRCC) being the most predominant subtype. Despite surgery being the main treatment, a significant portion of patients experience recurrence or metastasis, especially those with advanced disease. The Leibovich scoring system assists in predicting...Read more
2024 28 Feb
During a workshop on research presentations at ECR, authors from around the world shared recent advancements in studies exploring the association between AI and radiomics. Handcrafted radiomics, deep radiomics and transcriptomics data provide complementary and potentiating prognostic information in soft-tissue sarcoma patients Amandine Crombé...Read more
2024 28 Feb
During a workshop on research presentations at ECR, authors from around the world shared recent advancements in studies exploring the association between AI and radiomics. Handcrafted radiomics, deep radiomics and transcriptomics data provide complementary and potentiating prognostic information in soft-tissue sarcoma patients Amandine Crombé...Read more